演讲者

Sam Guhan, Vice President, Drug Product Technologies, Process Development , Amgen, USA

Sam Guhan, PhD is Vice President of Drug Product Technologies, Process Development at Amgen. Dr. Guhan joined Amgen in 2003. Prior to Amgen, he was at Pfizer's BioProcess R&D group. Dr. Guhan served as the Treasurer of the Biotechnology Division of the American Chemical Society, Read more..

Hitto Kaufmann, Global Vice President of Biopharmaceutical Development and Platform Innovation, Sanofi-Aventis, Germany
Palani Palaniappan, Head, Global Biologics & New Modalities,, Takeda, USA

Palani Palaniappan is Head of Global Biologics CMC and is responsible for biologics CMC activities within CMC Center in Takeda. Palani has been part of drug development teams for over 22 years Read more..

Koustuv Chatterjee, Executive Director, Head of Sterile Liquid Commercialization, , Merck & Co., USA

Koustuv Chatterjee, Ph.D., is the head of Sterile Liquid Commercialization group in Merck and Co., which is responsible for successful drug product development and commercialization of biologics, vaccines and sterile small molecules. Read more..

Peter Turecek, Senior Director in Global Medical Affairs, Baxalta, Austria

Dr Peter Turecek is Senior Director in Global Medical Affairs and acts as a Senior Scientific Advisor in charge of education for the BioScience business of Baxalta. Since joining Baxalta's research and development organization in 1989, Dr Turecek has held management positions in areas of vaccine development, recombinant blood clotting factors, downstream processing, and plasma fractionation, as well as diagnostics development and preclinical product characterization. Read more..

Joydeep Ganguly, Vice President, Corporate Engineering, Facilities and Operations, Gilead Sciences, USA
Hitoshi Kuboniwa, Senior Vice President - Pharmaceutical Technology, Chugai Pharmaceutical, Japan

Hitoshi is in charge of Pharmaceutical Technology Divison for process development and commercial manufacturing of both biologics and small molecules at Chugai. He has 36year's experiences in pharmaceutical industry, most of it with Chugai in discovery research, business development and senior management role of pharmaceutical technology. Read more..

Uwe Gottschalk, Chief Technology Officer, Lonza Pharma/Biotech

Before joining Lonza he served as Group Vice President at Sartorius Stedim Biotech between 2004 and 2014 with a global responsibility for all bioseparation-related process technology. Read more..

Zhang Peiqing, Analytical Science & Technology Coordinator, Novartis, Singapore

Zhang Peiqing is the Analytical Sciences and Technology (AS&T) Coordinator at Novartis Singapore BioProduction site. Prior to joining Novartis, he was the group leader of Analytics at Bioprocessing Technology Institute in A*STAR, Singapore. Read more..

Alison Ward, Director - Biologics Process Development,, ASLAN Pharmaceuticals, USA

Dr. Alison Ward is the Director for Biologics Process Development at ASLAN Pharmaceuticals. Alison has responsibility for progressing novel biological therapies into preclinical and clinical development. Read more..

Scott Liu, CEO & President, Henlius Biopharmaceuticals, USA

Dr. Scott Liu, graduated from Purdue University, Department of Biology, was a postdoctoral fellow at Stanford University, and later pursued iMBA courses at Syracuse University. As the Founder, President and CEO of Henlius Biopharmaceuticals, Inc. and Shanghai Henlius Biotech Co., Ltd.,he takes overall responsibility for strategic planning and implementation, as well as Read more..

Ronald Marchesani, Senior Vice President and Managing Director, Quality Assurance Center,, Samsung Biologics, Korea
Atin Tomar, CEO & President,, CPL Biologicals, India

Atin Tomar is President & CEO of CPL Biologicals Pvt. Ltd., a joint venture company formed between Cadila Pharmaceuticals Limited, India and Novavax Inc, USA in 2009. CPL Biologicals focuses on research & development, manufacturing and commercialization of Vaccines, Biologics and Diagnostics for human health. Read more..

Peter Shen, Vice President Process Development and Clinical Manufacturing, WuXi Biologics, China
Ko-Chung Lin, Founder and Chief Executive Officer, PharmaEssentia, Taiwan

Being the leading founder of PharmaEssentia, Dr. Lin is an accomplished scientist, receiving his Ph.D. from the University of Missouri, followed by postdoctoral research at the University of Michigan. With more than 20 years of successful experience in drug discovery and development, Read more..

Muri Han, Deputy General Manager, Upstream Process Team, Green Cross Research Center, Korea
Gary Khoo, Head of Manufacturing, Shire, Singapore

Gary Khoo has worked in Biotechnology products for the last 15 years. His experiences ranges from process development for mammalian cell processes (recombinant proteins and antibodies), development and operations of mid and late stage clinical products, technology transfer, start-up and manufacturing of commercial products, CMO operations and manufacturing. Read more..

Ronan McGarvey, Director - Quality Operations, AbbVie, Singapore
Lei Sun, President of Manufacturing, , AutekBio FTZ Inc., China

Prior to joining AutekBio, Dr. Sun has more than ten years of experience in development of therapeutic biologics and their production. He has also successfully led international teams in drug discovery research and the manufacture of therapeutic proteins. Read more..

Christopher Hwang, Executive Vice President, Process & Product Development, Hangzhou JUST Biotherapeutics,USA
Arleen Paulino, Vice President Singapore Site Operations, Amgen, Singapore
Giorgio Carta, Lawrence R. Quarles Professor, Department of Chemical Engineering, University of Virginia, USA
Steffen Kreye, Associate Director Upstream Process, Glycotope, Germany
Joseph Albert, Chief Technical Officer, AJ Pharma Holding, Malaysia
James Weidner (Advisory Board), Director, Process Engineering, Amgen, Singapore

James Weidner has 23 years of biotechnology experience with Amgen, Hoffmann-La Roche, and Biogen Idec. He has led Process Development, Manufacturing, Engineering and Automation groups in commercial facilities in the USA, Puerto Rico and Singapore. Read more..

Parimal Desai (Advisory Board), Vice President, Global Vaccines & Biologics Commercialization , Merck & Co., USA

Dr. Desai is currently Vice President, Global Vaccines & Biologics Commercialization at Merck in West Point, Pennsylvania, where he established a product development organization and associated technical and logistics systems to develop and commercialize Merck's vaccines and biologics including accelerated launch of Keytruda, a new class of immune-oncology drugs. He has also recently served as CEO of Hilleman Laboratories, India. Read more..

Srinivasan Raman (Advisory Board), Vice President & Head of Malaysia Operations , Biocon, Malaysia

An experienced biotech professional, who has held responsibilities in the core areas of Research, Facilities creation and Manufacturing. He has two international process patents to his credit. During the past decade , he has been responsible for the Biologicals manufacturing operations at Biocon,India. Currently he is heading the Biocon Malaysia operations. Read more..

Alan Liss (Advisory Board), Founder and CEO,, GXP-farma, LLC - Consulting (Former Director (MCMI PHSAT), US FDA)

Dr. Alan Liss has over 25 years of successful experience in the area of applied microbiology and biotechnology. He has focused on establishing and maintaining high quality pharmaceutical project management systems - directing teams of scientists and support staff to improve manufacturing efficiency and GXP regulatory compliance. Read more..

Joachim Walter (Advisory Board), Consultant, , Walter Biotech Consultancy, Germany

Dr. Walter got his education and PhD at the RWTH Aachen, Germany, and started his industrial career at Boehringer Ingelheim, Germany, in 1985. Here he became involved in the planning and establishing of a biotech facility, specifically responsible for establishing and leading the R&D Protein Chemistry within the Biopharmaceutical Division. Read more..

Alois Jungbauer, Professor, Department of Biotechnology, University of Natural Resources and Life Sciences, Austria

Alois focussed on Protein Technology and Downstream Processing and Bioprocess Engineering. He also acts as area head and Dep. Director of Research in the Austrian Centre of Industrial Biotechnology. Read more..

Peter R Levison, Senior Marketing Director - Downstream Processing, Pall Life Sciences
Choose your language
Chinese
Japanese
Korean
English



Platinum Sponsor

platinum_biologics_manufacturing_asia_2018

Gold Sponsor

Gold_Sponsor_Thermo

Silver Sponsors

silver_biologics_manufacturing_asia_2018

Exhibitors

exhibitors_biologics_manfuacturing_asia_2018

IN CONJUNCTION WITH

asia_pacific_bioprocessing_excellence_awards_2018

Co-Located With

biologistics_world_asia_event_2018_logo

免费电子邮件通知服务
中文官方网站营运: IMAPAC PTE. LTD.代理商 日商环球讯息有限公司